The Centers for Medicare and Medicaid Services said Tuesday it seeks to lower Medicare costs for 16 medications by negotiating with their manufacturers. Among them is Biktarvy, a drug taken after HIV ...
LGBTQ Nation on MSN
A cure for HIV is in sight. Here’s what scientists are working on.
"The future looks bright as far as a cure," one top HIV cure researcher told LGBTQ Nation.
Dolutegravir plus lamivudine demonstrates noninferiority to the standard-of-care three-drug regimen in treatment-naive patients with HIV without preliminary drug resistance testing. Researchers ...
By Chris Takudzwa Muronzi HARARE, Feb 19 (Reuters) - Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first ...
As patients with HIV live longer, menopause is becoming routine, but the science, safety data, and responsibility for managing it are still catching up.
Major trial finds immediate or high-dose TB treatment does not lower overall mortality in HIV-related sepsis, except in ...
Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting ...
Florida's proposed rule change to its AIDS Drug Assistance Program could cut off over 16,000 Floridians from life-saving ...
A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda. A multi-national, ...
Key goals of EHE include, from 2017 to the end of 2025, reducing new HIV infections and diagnoses by 75%, increasing viral suppression among PWH to 95%, and increasing good or better self-rated health ...
Shares fell as much as 6% in after-hours trading, a decline one analyst guessed may be because Yeztugo’s trajectory isn’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results